Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitotic catastrophe and cancer drug resistance: A link that must to be broken
Tatiana V. Denisenko, Irina Sorokina, Vladimir Gogvadze, et al.
Drug Resistance Updates (2015) Vol. 24, pp. 1-12
Closed Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
Lorenzo Galluzzi, Ilio Vitale, Stuart A. Aaronson, et al.
Cell Death and Differentiation (2018) Vol. 25, Iss. 3, pp. 486-541
Open Access | Times Cited: 5351
Targeting mutant p53 for cancer therapy: direct and indirect strategies
Jiahao Hu, Jiasheng Cao, Win Topatana, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 361
Therapeutic strategies to overcome taxane resistance in cancer
Tuyelee Das, Uttpal Anand, Swaroop Kumar Pandey, et al.
Drug Resistance Updates (2021) Vol. 55, pp. 100754-100754
Closed Access | Times Cited: 156
Mechanisms of cancer cell death induction by paclitaxel: an updated review
Shuang Zhao, Yufei Tang, Ruohan Wang, et al.
APOPTOSIS (2022) Vol. 27, Iss. 9-10, pp. 647-667
Closed Access | Times Cited: 113
Genetic alterations in hepatocellular carcinoma: An update
Zhao-Shan Niu, Xiao-Jun Niu, Wenhong Wang
World Journal of Gastroenterology (2016) Vol. 22, Iss. 41, pp. 9069-9069
Open Access | Times Cited: 153
Non-Canonical Cell Death Induced by p53
Atul Ranjan, Tomoo Iwakuma
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 12, pp. 2068-2068
Open Access | Times Cited: 116
A Review on Curability of Cancers: More Efforts for Novel Therapeutic Options Are Needed
Shuncong Wang, Yewei Liu, Yuanbo Feng, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1782-1782
Open Access | Times Cited: 89
Discovery of ATR kinase inhibitor berzosertib (VX-970, M6620): Clinical candidate for cancer therapy
Lukáš Górecki, Martin Andrš, Martina Řezáčová, et al.
Pharmacology & Therapeutics (2020) Vol. 210, pp. 107518-107518
Closed Access | Times Cited: 86
A link between mitotic defects and mitotic catastrophe: detection and cell fate
Elena V. Sazonova, С. В. Петричук, Gelina S. Kopeina, et al.
Biology Direct (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 79
Clinical Candidates Targeting the ATR–CHK1–WEE1 Axis in Cancer
Lukáš Górecki, Martin Andrš, Jan Korábečný
Cancers (2021) Vol. 13, Iss. 4, pp. 795-795
Open Access | Times Cited: 78
Programmed cell death: Past, present and future
Gelina S. Kopeina, Boris Zhivotovsky
Biochemical and Biophysical Research Communications (2022) Vol. 633, pp. 55-58
Open Access | Times Cited: 58
Current evidence and therapeutic implication of PANoptosis in cancer
Dickson Kofi Wiredu Ocansey, Fei Qian, Peipei Cai, et al.
Theranostics (2023) Vol. 14, Iss. 2, pp. 640-661
Open Access | Times Cited: 33
SIRT1 modulates cell cycle progression by regulating CHK2 acetylation−phosphorylation
Wenyu Zhang, Yanling Feng, Qiqiang Guo, et al.
Cell Death and Differentiation (2019) Vol. 27, Iss. 2, pp. 482-496
Open Access | Times Cited: 64
The DNA-damage response and nuclear events as regulators of nonapoptotic forms of cell death
Evgeniia Prokhorova, Aleksandra Yu. Egorshina, Boris Zhivotovsky, et al.
Oncogene (2019) Vol. 39, Iss. 1, pp. 1-16
Closed Access | Times Cited: 64
There are only four basic modes of cell death, although there are many ad-hoc variants adapted to different situations
Xingde Liu, Wenxiu Yang, Zhi-Zhong Guan, et al.
Cell & Bioscience (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 63
Inhibition of the lncRNA MIAT prevents podocyte injury and mitotic catastrophe in diabetic nephropathy
Ziyang Wang, Ying Chang, Yue Liu, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 28, pp. 136-153
Open Access | Times Cited: 31
Perspectives and mechanisms for targeting mitotic catastrophe in cancer treatment
Zhaoshi Bai, Yiran Zhou, Yaling Peng, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188965-188965
Closed Access | Times Cited: 19
Withanolides: Promising candidates for cancer therapy
Qiang Zhang, Yongkang Yuan, Shijie Cao, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 2, pp. 1104-1158
Closed Access | Times Cited: 7
Synergistic induction of mitotic pyroptosis and tumor remission by inhibiting proteasome and WEE family kinases
Zhan‐Li Chen, Chen Xie, Wei Zeng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Developing a prognosis and chemotherapy evaluating model for colon adenocarcinoma based on mitotic catastrophe-related genes
Yinglei Liu, Zhao Ya-min, Siming Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Narciclasine induces autophagy‐dependent apoptosis in triple‐negative breast cancer cells by regulating the AMPK‐ULK1 axis
Chuan Ping CAO, Wei Huang, Nan Zhang, et al.
Cell Proliferation (2018) Vol. 51, Iss. 6
Open Access | Times Cited: 48
Replication stress induces mitotic death through parallel pathways regulated by WAPL and telomere deprotection
V. Pragathi Masamsetti, Ronnie Ren Jie Low, Ka Sin Mak, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 47
The dynamic role of nucleoprotein SHCBP1 in the cancer cell cycle and its potential as a synergistic target for DNA-damaging agents in cancer therapy
Mei Zhou, Limin Duan, Jiangbin Chen, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Nanomedicine-induced programmed cell death in cancer therapy: mechanisms and perspectives
Luobin Lin, He Wanxin, Yingxin Guo, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Targeted inhibition of Hedgehog-GLI signaling by novel acylguanidine derivatives inhibits melanoma cell growth by inducing replication stress and mitotic catastrophe
Silvia Pietrobono, Roberta Santini, Sinforosa Gagliardi, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 2
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top